Eli Lilly launches oral weight-loss pill Foundayo in UK
This digest was compiled by AI from multiple sources — links to the originals are below.
Eli Lilly launched its oral weight-loss pill Foundayo in the UK on Monday, making it the first European country where the treatment is available. The pill, known chemically as orforglipron, will be available via private prescription after Britain's medicines regulator authorised it on August 10. Lilly said Foundayo will likely be priced between £100 and £120, lower than its Mounjaro injection's £330 for a month's supply.
Key Facts
- Eli Lilly launched Foundayo in the UK on Monday, making it the first European country where the oral weight-loss pill is available.
- Britain's medicines regulator authorised Foundayo on August 10, making it the second GLP-1 oral pill cleared in the UK after Novo Nordisk's Wegovy.
- Lilly said Foundayo will likely be priced between £100 and £120 per month, compared with £330 for its Mounjaro injection.
- Lilly is working with England's National Institute for Health and Care Excellence on a potential rollout at the state-run National Health Service.
- Foundayo remains under review in the European Union, while Novo Nordisk's Wegovy pill has received a positive recommendation from the European Medicines Agency.
UK Launch
Eli Lilly launched its oral weight-loss pill Foundayo in the UK on Monday, making it the first country in Europe where the treatment is available. The pill, known chemically as orforglipron, will be available via private prescription after Britain's medicines regulator authorised the drug on August 10. Foundayo is the second GLP-1 oral pill to be cleared in the UK after Novo Nordisk's Wegovy. Lilly said it was working with England's health cost-effectiveness watchdog, the National Institute for Health and Care Excellence, on a potential roll-out at the state-run National Health Service.
Pricing and Market Position
Lilly said Foundayo will likely be priced between £100 and £120, lower than its Mounjaro injection's £330 for a month's supply. Foundayo remains under review in the European Union, while Novo Nordisk's Wegovy pill has won a positive recommendation from the European Medicines Agency, with a final decision from the European Commission pending.
2 sources
Eli Lilly launches oral weight-loss pill Foundayo in UK
